Project Grant K12TR006368
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $1.62 million on August 1, 2026, under the NCATS program (CFDA 93.350) to operate a mentored research career development program in clinical and translational science. The University of Pennsylvania will identify, recruit, train, and retain nine early-career scientists across varied educational backgrounds and professional experiences, guiding them toward scientific independence and leadership in...
- The National Center for Advancing Translational Sciences awarded a cooperative agreement totaling $7.892 million to Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) on August 6, 2026, under CFDA 93.350. The award funds the Penn State Clinical and Translational Science Institute (CTSI) to advance clinical and translational science through investigator-centered research infrastructure, development and dissemination of innovations, expansion of Pennsylvania's...
- The National Center for Advancing Translational Sciences awarded University of Massachusetts Medical School $949,994 on April 1, 2026, under the NCATS program (CFDA 93.350) to support a K12 career development program in translational science. The award funds the development and mentorship of junior faculty scholars pursuing careers in translational science. The program will support four NCATS-funded scholars at any given time, forming the core of a nine-scholar umbrella initiative that...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $1,025,770 on August 1, 2026, under the NCATS K12 Program (CFDA 93.350) to develop the next generation of clinical and translational research experts and translational scientists. The University of Pittsburgh will train scholars in translational science and domain-specific skills required for careers as clinical and translational researchers and translational scientists, provide cross-disciplinary...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $553,631 on July 6, 2026, under the CTSA Predoctoral T32 program (CFDA 93.350) to support predoctoral trainee development in clinical and translational science. The award funds a predoctoral training program that will support 10 trainees at any given time, recruited from PhD, MD, DMD, and VMD doctoral programs, with individual appointments lasting 1–3 years depending on career stage. The training plan...
- The National Center for Advancing Translational Sciences awarded a $10.805 million Cooperative Agreement to the University of Pennsylvania on July 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). The Penn-CHOP Clinical and Translational Science Award (CTSA) Hub will advance clinical and translational science through four integrated aims: developing and disseminating novel approaches to translational therapeutics; applying data science resources and...
- The National Center for Advancing Translational Sciences awarded New York University $6.28 million on April 15, 2026, under the CTSA K12 Program (CFDA 93.350) to train early-stage clinical and translational researchers through career development at the NYU Clinical Translational Science Institute. The award funds a structured training program composed of didactic courses, experiential learning, and individualized leadership coaching. Scholars receive mentorship from at least two science mentors,...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $558,631 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to develop and deliver predoctoral training in clinical and translational research and translational science. The University of Pittsburgh's Institute for Clinical Research Education (ICRE), in collaboration with the Clinical and Translational Science Institute (CTSI), will train the next...
- The National Center for Advancing Translational Sciences awarded the University of California Irvine $1.512 million on March 15, 2026, under the NCATS K12 Project Grant program (CFDA 93.350) to establish a mentored career development core for clinical translational science and research. The program supports the training of four K12 scholars per year through structured mentorship, individual development planning, and scholar-mentor alignment oversight. UCI operates an affiliated scholars...
The National Center for Advancing Translational Sciences awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $725,350 on August 13, 2026, under the NCATS K12 Program (CFDA 93.350) to support early-career faculty development in translational science. The award funds a structured 2–3 year intensive career development and research training program for 3 cohorts of early-career faculty scholars (3 scholars per cohort), organized around three pillars: careers, science, and community. The careers pillar includes individualized mentorship to accelerate career development, structured coaching and training to develop future leaders and mentors, and resources and strategies to support resilience in navigating academic challenges. The science pillar encompasses a comprehensive translational science curriculum, interdisciplinary team science training, grant-writing proficiency development to secure independent research funding, and engagement with rural health community mentors to integrate new perspectives into research. The community pillar focuses on rural populations in Pennsylvania, reflecting the institution's commitment to community-engaged research and improving health outcomes in rural areas. Performance occurs in Hershey, Pennsylvania, with an ultimate completion date of May 31, 2031. The award is classified as a Project Grant under NCATS, which funds translational science activities to reduce bottlenecks in the research pipeline and accelerate delivery of new diagnostics and therapeutics to patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $725.4k | 8/13/26 |